4 C
New York
Wednesday, November 13, 2024

Elizabeth Warren and the FTC Are the Least of Amgen’s Problems

Amgen isn’t getting much love from Washington these days. The Internal Revenue Service has gone after the biotech for billions of dollars in back taxes. Lina Khan’s Federal Trade Commission is seeking to block its $27.8 billion acquisition of Horizon Therapeutics (a move some insiders think was at …

This post was originally published on this site

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

156,500FansLike
396,312FollowersFollow
2,320SubscribersSubscribe

Latest Articles

0
Would love your thoughts, please comment.x
()
x